The majority of drugs used to treat asthma today are the same ones that were used 50 years ago. Tissue-level model of human airway musculature could pave way for patient-specific asthma treatments
New drugs are urgently needed to treat this chronic respiratory disease, which causes nearly 25 million people in the United States alone to wheeze, cough, and find it difficult at best to take a deep breath.
But finding new treatments is tough: asthma is a patient-specific disease, so what works for one person doesn’t necessarily work for another, and the animal models traditionally used to test new drug candidates often fail to mimic human responses–costing tremendous money and time.
Hope for healthier airways may be on the horizon thanks to a Harvard University team that has developed a human airway muscle-on-a-chip that could be used to test new drugs because it accurately mimics the way smooth muscle contracts in the human airway, under normal circumstances and when exposed to asthma triggers. As reported in the journal Lab on a Chip, it also offers a window into the cellular and even subcellular responses within the tissue during an asthmatic event.
“Every year asthma costs many tens of billions of dollars, significant productivity due to lost work and school days, and even lives,” said senior author Kevin Kit Parker, Ph.D., a Core Faculty member at Harvard’s Wyss Institute for Biologically Inspired Engineering and Tarr Family Professor of Bioengineering and Applied Physics at the Harvard School of Engineering and Applied Sciences (SEAS). Parker leads development of the Wyss Institute’s heart-on-a-chip technology as well and is specifically interested in diseases that affect children. “We were thrilled with how well the chip recapitulated the functioning of the human airway.”
The chip, a soft polymer well that is mounted on a glass substrate, contains a planar array of microscale, engineered human airway muscles, designed to mimic the laminar structure of the muscular layers of the human airway.
To mimic a typical allergic asthma response, the team first introduced interleukin-13 (IL-13) to the chip. IL-13 is a natural protein often found in the airway of asthmatic patients that mediates the response of smooth muscle to an allergen.
Then they introduced acetylcholine, a neurotransmitter that causes smooth muscle to contract. Sure enough, the airway muscle on the chip hypercontracted – and the soft chip curled up – in response to higher doses of the neurotransmitter.
They achieved the reverse effect as well and triggered the muscle to relax using drugs called ?-agonists, which are used in inhalers.
Significantly, they were able to measure the contractile stress of the muscle tissue as it responded to varying doses of the drugs, said lead author Alexander Peyton Nesmith, a Ph.D./M.D. student at Harvard SEAS and the University of Alabama at Birmingham. “Our chip offers a simple, reliable and direct way to measure human responses to an asthma trigger,” he said.
The Latest on: Asthma
via Google News
The Latest on: Asthma
- Second-hand smoke exposure a likely risk factor for developing asthma for future generationson September 19, 2022 at 7:30 am
According to a new study, Children are more prone to develop asthma if their father was exposed to second-hand smoke when he was a child.The study also shows that children's risk of asthma is even ...
- Single inhaler therapy decreases frequency and intensity of asthma exacerbations: Reviewon September 19, 2022 at 7:30 am
USA: A recent study published in Annals of Allergy, Asthma & Immunology on July 2022 found that some of the clinical trials supported single maintenance and reliever therapy (SMART's) efficacy, ...
- First multi-center, large-scale registry of severe asthma patients launched in Singaporeon September 19, 2022 at 5:56 am
This national registry also joins the International Severe Asthma Registry (ISAR), making it the largest international research collaboration in the history of respiratory medicine in Singapore. The ...
- We're in 'peak week' for hospitalizations for children with asthmaon September 19, 2022 at 1:42 am
Doctors identified the third week of September as the peak week for asthma attacks, hospitalizations and trips to the ER. Here's why.
- TO YOUR GOOD HEALTH: Hiatal hernia not correlated to asthma medicationon September 18, 2022 at 5:28 pm
I am 80 years old, still work full-time and have generally good health, except for adult-onset asthma. Advair 250/50 was prescribed for me over 10 years ago, ...
- How To Tell The Difference Between An Asthma Attack And A Panic Attackon September 18, 2022 at 4:00 am
If you've ever experienced a sudden tight chest and had problems breathing, you might have wondered whether you were having an asthma attack or a panic attack.
- Patients With Asthma May Move Too Quickly to Biologics, Researchers Sayon September 17, 2022 at 1:22 pm
The retrospective claims database analysis looked at patients in the United States, where it is estimated that costs related to asthma are more than $80 billion annually.
- Study shows hay fever among school children leads to worse asthma outcomeson September 16, 2022 at 11:33 pm
A study of school children conducted by University of Rochester Medical Center researchers has found that the majority of children with asthma also reported having allergic rhinitis, or hay fever.
- Youth more likely to develop asthma if their father was exposed to secondhand smokeon September 16, 2022 at 11:30 am
Story at a glance Exposure to air pollution, like secondhand smoke, can lead to lung problems and asthma. Children are especially vulnerable. Data from a longitudinal study suggests that grandchildren ...
- Detroit named most challenging place to live in U.S. with asthmaon September 16, 2022 at 8:22 am
The city of Detroit has been ranked as the most challenging place in the United States to live with asthma. The Asthma and Allergy Foundation of America has ranked the most challenging places in the U ...
via Bing News